| UniProt/SwissProt ID: | KI2L1_HUMAN |
| Description: | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 [Source:HGNC Symbol;Acc:6329] |
| Location: | chr19 q13.42 |
| Node attribute: | receptor |
|
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|
| T311 | NHCVFtQRKIT | | PhosphoSitePlus |
| Y302 | PQEVTyTQLNH | | PhosphoSitePlus |
| Y332 | TDIIVyTELPN | | PhosphoSitePlus |
| T180 | PKVNGtFQADF | ig | PhosphoSitePlus |
| S281 | VMDQEsAGNRT | | PhosphoSitePlus |
|
KI2L1_HUMAN do not have dephosphorylation site.
|
|
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|
| ENSP00000336769 | R99I | BIOMART | Breast Cancer | 21930507, 21930502 |
|
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|
| ENSP00000336769 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 3 hour) | cell line | Up | 1.6 | 15169874 |
|
| KI2L1_HUMAN do not have hyperphosphorylation site. |
|
| KEGG ID | Pathway |
|---|
| hsa04650 | Natural killer cell mediated cytotoxicity |
| hsa05332 | Graft-versus-host disease |
| hsa04612 | Antigen processing and presentation |
|
| GO ID | GO_Term | Evidence | Ontology |
|---|
| GO:0004872 | receptor activity | TAS | molecular_function |
| GO:0002769 | natural killer cell inhibitory signaling pathway | IDA | biological_process |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0050776 | regulation of immune response | TAS | biological_process |
| GO:0005887 | integral to plasma membrane | TAS | cellular_component |
| GO:0006955 | immune response | TAS | biological_process |
| GO:0005886 | plasma membrane | IDA | cellular_component |
|
: Uncaught Error: Call to undefined function mysql_close() in /usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php:23
Stack trace:
#0 /usr/local/apache/htdocs/PhoSigNet/proteintable.php(435): db_disconnect(Object(mysqli))
#1 {main}
thrown in
/usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php on line
23
